Emphysema

The Lung Microbiome and Endobronchial Valve Treatment

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

Zephyr Valve Registry (ZEVR)

Zephyr Valve Japan Post-Marketing Surveillance

STRIVE Post-Market Registry Study

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

Endobronchial Silicone Valve for Patients With Emphysema

DIVision of the Interlobar Fissure in Patients Who Do Not Respond to Endobronchial Lung Volume Reduction

A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

Lung Disease and FLNA Mutations

Clinical-ultrasonographic Assessment of Pulmonary Emphysema

Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)

Anti-Platelets in Chronic Obstructive Pulmonary Disease

Analysing Peripheral Skeletal Muscle Function Before and After Endobronchial Valve Treatment

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA

Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema

A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema

Emphysema and FLNA Mutation (E-FLNA)